Table 13: A1C at Week 12 in a Placebo-Controlled Trial of Saxagliptin in Patients with Renal Impairment* The cardiovascular risk of saxagliptin was evaluated in SAVOR, a multicenter, multinational, randomized, double-blind trial
6.2 Role of ferroptosis in ARDS subphenotypes ARDS is a heterogenous syndrome with distinct subphenotypes, including hyperinflammatory and hypoinflammatory forms, which differ in pathophysiology, clinical presentation, and response to treatment
Temperature excursions above 77 degrees Fahrenheit cause accelerated degradation of the peptide
B-12 Lipo-Plus injections combine Vitamin B-12 with powerful lipotropic compounds to create an effective energy enhancement system
The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial